| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ADP-ribosylation inhibitors in treatment of diseases
|
Bai, Peter
|
|
2019
|
167 |
C |
p. 1-2
|
artikel
|
| 2 |
Development of renal failure in PargParp-1 null and Timm23 hypomorphic mice
|
Chen, Lichao
|
|
2019
|
167 |
C |
p. 116-124
|
artikel
|
| 3 |
Editorial Board
|
|
|
2019
|
167 |
C |
p. ii
|
artikel
|
| 4 |
Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways
|
Bu, Xiangning
|
|
2019
|
167 |
C |
p. 44-49
|
artikel
|
| 5 |
Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation
|
Lu, Alvin Z.
|
|
2019
|
167 |
C |
p. 97-106
|
artikel
|
| 6 |
Evaluating the potential of kinase inhibitors to suppress DNA repair and sensitise ovarian cancer cells to PARP inhibitors
|
Mukhopadhyay, Asima
|
|
2019
|
167 |
C |
p. 125-132
|
artikel
|
| 7 |
Human alcohol dehydrogenase 1 is an acceptor protein for polyADP-ribosylation
|
Yamashita, Sachiko
|
|
2019
|
167 |
C |
p. 27-32
|
artikel
|
| 8 |
Influence of onconase in the therapeutic potential of PARP inhibitors in A375 malignant melanoma cells
|
Raineri, Alice
|
|
2019
|
167 |
C |
p. 173-181
|
artikel
|
| 9 |
Mitotic functions of poly(ADP-ribose) polymerases
|
Slade, Dea
|
|
2019
|
167 |
C |
p. 33-43
|
artikel
|
| 10 |
New insights of poly(ADP-ribosylation) in neurodegenerative diseases: A focus on protein phase separation and pathologic aggregation
|
Liu, Cong
|
|
2019
|
167 |
C |
p. 58-63
|
artikel
|
| 11 |
Non-NAD-like PARP-1 inhibitors in prostate cancer treatment
|
Karpova, Yaroslava
|
|
2019
|
167 |
C |
p. 149-162
|
artikel
|
| 12 |
Olaparib induces browning of in vitro cultures of human primary white adipocytes
|
Nagy, Lilla
|
|
2019
|
167 |
C |
p. 76-85
|
artikel
|
| 13 |
Overview of the mammalian ADP-ribosyl-transferases clostridia toxin-like (ARTCs) family
|
Di Girolamo, Maria
|
|
2019
|
167 |
C |
p. 86-96
|
artikel
|
| 14 |
PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders
|
Grimaldi, Giovanna
|
|
2019
|
167 |
C |
p. 64-75
|
artikel
|
| 15 |
Poly(ADP-ribose)-dependent ubiquitination and its clinical implications
|
Vivelo, Christina A.
|
|
2019
|
167 |
C |
p. 3-12
|
artikel
|
| 16 |
Poly(ADP-ribosylated) proteins in β-amyloid peptide-stimulated microglial cells
|
Correani, Virginia
|
|
2019
|
167 |
C |
p. 50-57
|
artikel
|
| 17 |
Targeting ADP-ribosylation as an antimicrobial strategy
|
Catara, Giuliana
|
|
2019
|
167 |
C |
p. 13-26
|
artikel
|
| 18 |
Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders
|
Faraoni, Isabella
|
|
2019
|
167 |
C |
p. 133-148
|
artikel
|
| 19 |
Targeting poly(ADP-ribose) glycohydrolase to draw apoptosis codes in cancer
|
Tanuma, Sei-ichi
|
|
2019
|
167 |
C |
p. 163-172
|
artikel
|
| 20 |
Therapeutic considerations of PARP in stem cell biology: Relevance in cancer and beyond
|
Zeniou, M.
|
|
2019
|
167 |
C |
p. 107-115
|
artikel
|
Tijdschrift beschrijving